600 patients66,869 observations120 daysLIVE
← Patients

Patient P-01369

Synthetic patientNBL-101 · Day 107 · 45–54 · F · baseline S08Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
9%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 started — Baseline state S08

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Inflammatory activity-6
  • Treatment adherence-4
  • Nutritional resilience-3
  • Toxicity+3
  • GI instability-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    GI burden
    Companion
    10.6/100
    worsening · +2.5 vs previous 14 d
    Toxicity
    Blood
    16.2/100
    stable · +0.2 vs previous 14 d
    Sleep quality
    Wearable
    64.8/100
    improving · +2.2 vs previous 14 d
    Energy level
    Daily log
    6.3/10
    stable · -0.2 vs previous 14 d
    Stress level
    Daily log
    2.7/10
    worsening · +0.2 vs previous 14 d
    Steps
    Wearable
    5,548
    stable · -172 vs previous 14 d
    Adherence
    Companion
    89 %
    stable · -2.7 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 87 from the failing basin, 13 from restoration.

    Good elements to keep
    • Butyrate producers intact
      hidden · steering +7.5
    • Daily walks resumed
      perturbation · steering +3.3
    Main detractors to watch
    • Low-HRV stretch
      perturbation · steering -2.7
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Spicy / capsaicin
      +0.7no signal · 21%
    • Dietary fat load
      +0.4no signal · 15%
    • Histamine load
      +0.4no signal · 15%
    • Simple carbohydrates
      -0.4no signal · 15%
    • Alcohol
      +0.3no signal · 15%
    • Insoluble fibre
      -0.1no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
      DNA
      Fictional pharmacogenomic panel
      • CYP2D6 Normal metabolizer
        Expected exposure
      Microbiome
      Shannon diversity 3.1 · butyrate capacity 45/100
      • Akkermansia muciniphilaNormal
      • Faecalibacterium prausnitziiNormal
      • Bacteroides fragilisNormal
      • Bifidobacterium longumLow
      • EnterobacteriaceaeNormal
      Wearable, last 14 days
      daily evolution fed into the runtime
      HRV
      56 ms
      Sleep
      6.9 h
      Steps
      4,585
      Resting HR
      56 bpm
      Daily log: GI score 11, nutritional resilience 68, adherence 89.

      What this patient sees in NostraAI

      The content that steers the trajectory: what to eat, what to do, what to take.

      Open companion preview
      What to eat
      • Keep meals regular; three to four moderate portions spaced through the day
      • Include a cooked vegetable portion with each main meal
      • Keep fibre steady; no new sources this week
      • Avoid known triggers for now: fried or oily food, dairy, alcohol
      What to do
      • Log the daily check-in; one line is enough
      • Keep the current walking rhythm
      • Keep the sleep window steady
      • Keep hydration steady: small amounts through the day rather than large volumes at once
      What to take
      • Take the scheduled dose as agreed with your care team
      • No additional supplements this week
      • Fictional demo item: continue vitamin D as before

      284 biologically similar trajectories

      Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

      Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
      PatientSimilarityBaselineInterventionOutcomeResponse today
      P-0176637%S05AD-05no change90
      P-0154132%S09AD-05no change43
      P-0180432%S19AD-05improved61
      P-0132946%S08BR-03improved79
      P-0167737%S05BR-03no change86
      P-0149536%S07BR-03improved85
      P-0165439%S08CR-01improved85
      P-0143032%S05CR-01improved54
      P-0172439%S10DT-01improved63
      P-0185539%S04DT-01improved73
      P-0147936%S15DT-01improved84
      P-0176736%S14DT-01no change63